Iopodic acid is an iodine containing cholecystography agent. Due to its particular structure, it presents a high degree of lipid solubility and a radiopaque property.
- Mechanism
- Curator reviewed · 3 references
For cholecystography, iopodic acid blocks the X-rays as they pass through the body which allows delineating the body structures that do not contain this compound.
The use of iopodic acid in hyperthyroidism is related to the inhibition of 5'-monodeiodinase type I and II; this will later impair the extrathyroidal conversion of thyroxine (T4) to triiodothyronine (T3).
- Primary indication
- Iopodic acid is available as a cholecystographic agent.Curator reviewed
- Formula / weight
- C12H13I3N2O2 · 597.961 g/mol (avg)
- First approval
- Canada, 1997
- Also known as
- Ipodate
Resolves to
YQNFBOJPTAXAKV-UHFFFAOYSA-NSMILESCN(C)C=NC1=C(I)C=C(I)C(CCC(O)=O)=C1IWhat you can answer from here — as of August 30, 2026
Which drugs share a target with Iopodic acid, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account